Literature DB >> 12727006

Duration of symptoms in patients with infective endocarditis.

Victor Sarli Issa1, José Fabri, Pablo M A Pomerantzeff, Max Grinberg, Antonio Carlos Pereira-Barreto, Alfredo José Mansur.   

Abstract

Despite progress in the management of infective endocarditis, delays in diagnosis or prior antimicrobial treatment may adversely influence the symptom duration and outcome. The duration of symptoms in patients with infective endocarditis was studied in 683 cases among 653 patients with 703 episodes of the disease; patients were hospitalized within 10 days of symptom onset in 169 (24.7%) cases. Antimicrobial therapy before hospital admission was administered to 257 (36.5%) patients. Overall mortality was 25.6%. Symptom duration was longer when antimicrobials were administered before diagnosis (58.8+/-78.1 vs. 44.8+/-54.9 days), when vegetations were detected on echocardiogram (53.5+/-68.2 vs. 38.8+/-47.3) and among patients admitted before 1990 (42.3+/-67.1 vs. 54.2+/-62.4 days). Symptom duration was shorter in patients with prosthetic valve endocarditis (26.8+/-34.2 vs. 59.3+/-71.6 days). In 54 (26.5%) episodes of prosthetic valve endocarditis, patients had symptoms for more than 30 days. Staphylococcus aureus was the most frequent agent among patients with symptoms up to 10 days (41.2%) and Streptococcus among those with symptoms over 20 days (53.9%). Symptom duration did not significantly differ in regard to medical (51.3+/-69.2 days) or surgical (46.7+/-55.7 days) treatment. Mortality increased as symptom duration decreased and was highest for patients who experienced symptoms for less than 10 days (36.1%). In some patients medical care may be delivered relatively late in the course of infective endocarditis. Administration of antibiotics previous to hospital admission increased duration of symptoms, and cardiac valve prosthesis, staphylococcal infection and death were associated with more acute disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727006     DOI: 10.1016/s0167-5273(02)00424-2

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

Review 1.  Infective endocarditis epidemiology over five decades: a systematic review.

Authors:  Leandro Slipczuk; J Nicolas Codolosa; Carlos D Davila; Abel Romero-Corral; Jeong Yun; Gregg S Pressman; Vincent M Figueredo
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

2.  Dental Procedures and the Risk of Infective Endocarditis.

Authors:  Pei-Chun Chen; Ying-Chang Tung; Patricia W Wu; Lung-Sheng Wu; Yu-Sheng Lin; Chee-Jen Chang; Suefang Kung; Pao-Hsien Chu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

3.  Incidence, Microbiology, and Outcomes in Patients Hospitalized With Infective Endocarditis.

Authors:  Anoop S V Shah; David A McAllister; Peter Gallacher; Federica Astengo; Jesús Alberto Rodríguez Pérez; Jennifer Hall; Kuan Ken Lee; Rong Bing; Atul Anand; Dilip Nathwani; Nicholas L Mills; David E Newby; Charis Marwick; Nicholas L Cruden
Journal:  Circulation       Date:  2020-05-15       Impact factor: 29.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.